Update on the diagnosis and treatment of Henoeh-Sch(o)nlein purpura in children

( views:685, downloads:0 )
Author:
WANG Shi-jie(Dcpartment of Pediatrics,First Affiliated Hospital of Anhui Medical University,Hefei 230022,China)
LU Ling(Dcpartment of Pediatrics,First Affiliated Hospital of Anhui Medical University,Hefei 230022,China)
Journal Title:
INTERNATIONAL JOURNAL OF DERMATOLOGY AND VENEREOLOGY
Issue:
Volume 35, Issue 02, 2009
DOI:
10.3760/cma.j.issn.1673-4173.2009.02.012
Key Word:
Purpuga,Sch(o)nlein-Henoch;Child;Diagnosis;Therapy

Abstract: Henoch-Schisnlein purpura is a common systemic vasculitis in childhood.Palpable purpura is the mandatory criterion for the diagnosis of this disease in the new criteria.Early diagnosis is difficult in children who presented initially with abdominal pain.Gastroscopy and detection of the activity of coagulation factor (ⅩⅢ) may facilitate its early diagnosis.The serum level of insulin-like growth factor,insulin-like growth factor binding protein 3 and urine epidermal growth factor can predict renal damage in allergic purpura,so as to provide a basis for clinical intervention.Henoch-Sch onlein purpura is primarily dealed with medication.In particular,glucocorticoid and immunosuppressants can effectively control the disease and improve its prognosis.Mycophenolate has exhibited a good prospect in the treatment of this disease.

  • [1]Mills JA,Michel BA,Bloch DA,et al.The American College of Rheumatology 1990 criteria for the classification of Henoch-Sch(o)alein purpura.Arthritis Rhearn.1990,33(8):1114-1121.
  • [2]Ozen S,Ruperto N.Dillon MI,et al.EULA R/PReS endorsed consensus critena for the classification of childhood vasculitldes.Ann Rhcam DIS,2006,65(7):936-941.
  • [3]Aalberse J,Dolman K,Ranmath G,et al.Henoch-Sch(o)nlein purpura in children:an epidemiological study among Dutch paediatricians on incidence and diagnostic criteria.Ann Rheum Dis,2007,66(12):1648-1650.
  • [4]Trapani S,Micheli A,Grisolia F,et al.Henoch-Schanlein purpura in childhood:epidemiological and clinical analysis of 150 eases ovel-a 5-year period and review of litemture.Semin Arthritis Rheum,2005;35(3):143-153.
  • [5]Preud'Homme DL,Michail S,Hodges C,et al.Use of wireless capsule endoscopy in the management of severe Henoch-Sch(o)nlein purpura.Pcdiatrics.2006,118(3):e904-906.
  • [6]Kawasaki K,Komura H,Nakahara Y,et al.Factor (ⅩⅢ) in Henoch-Schi(o)nlein purpura with isolated gastrointestinal symptoms.Pediatr Int,2006,48(4):413-415.
  • [7]Shin JI,Lee JS.Severe gastrointestinal vasculitis in Henoch-Sch(o)enlein purpura:pathophysiologic mechanisms,the diagnostic value of factor (ⅩⅢ),and therapeutic options.Eur J Pediatr,2007,166(11):1199-200.
  • [8]Shin JI,Lee JS.Could measurement of factor (ⅩⅢ) level detect the vasculitic process of Henoch-Schtmlein purpura without skin rash?Aeta Paediatr,2008,97(4):395-395.
  • [9]Yildiz B,Kural N,Aydin B,et al.Increased serum levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3 in Henoch-Sch(o)nlein purpura.Tohoku j Expmed,2008,214(4):333-340.
  • [10]孙清,陈宗波,王一冰,等.尿表皮生长因子质量浓度检测对紫癜性肾炎患儿的早期诊断价值.中国实用儿科杂志,2007,22(2):108-110.
  • [11]陈华,张亚京,王鑫,等.尿微量蛋白和尿酶在儿童过敏性紫癜早期肾损伤中的临床意义.中国实_刚儿科杂志,2007,22(2):111-112.
  • [12]Shin JI,Park JM,Shin YH,et al.Predictive factors for nephritis,relapse.and significant proteinuria in childhood Henoch-Sch(o)nlein purlcIura.Scand J Rheumatol,2006,35(1):56-60.
  • [13]de Almeida JL,Campos LM,Paim LB,et al.Renal involvement in Henoch-Sch(o)nlein purpura:a multivariate analysis of initial prognostic factors.J Pediatr (Rio J),2007,83(3):259-266.
  • [14]Rigante D,Candelli M,Fedefico G,et al.Predictive factors of renal involvement or relapsing disease in children with Henoch-Schanlein purpura.Rheumatol Int,2005,25(1):45-48.
  • [15]Huber AM,King J,Mclaine T,et al.A randomized placebo-controlled trial of prednisone in early Henoch-Sch(o)nlein Purpura.BMC Med,2004,2:7.
  • [16]Ronkainen J,Koskimies O,Ala-Houhala M,et al.Early prednisone therapy in Henoch-Schtinlein purpura:a randomized,double-blind,placebo.controlled trial.J Pediatr,2006,149(2):241-247.
  • [17]Weiss PF,Feinstein JA,Luan X,et al.Effects of eorticosteroid on Henoch.Sch(o)nlein purpum:a systematic review.Pediatrics,2007,120(5):1079-1087.
  • [18]Zaffanello M,Bmgnam M,Fmnchini M.Therapy for children with Henoch-Schlmlein purpura nephritis:a systematic review.Sci World Journal,2007,10(7):20-30.
  • [19]俞全胜,朱光华,何威逊,等.霉酚酸酯与环磷酰胺治疗肾病综合征型紫癜性肾炎疗效比较.临床儿科杂志,2007,25(4):271-273.
  • [20]Inoue CN,Chiba Y,Morimoto T,et al.Tonsillectomy in the treatment of pediatric Henoch.Sch(O)nlein nephritis.Clin Nephrol,2007,67(5):298-305.
  • [21]Mir S,Yavascan O,Mutlubas F,et al.Clinical outcome in children with Henoch.Sch(o)inlein nephritis.Pediatr Nephrol,2007,22(1):64-70.
  • [22]Shenoy M,Bmdbury MG,Lewis MA,et al.Outcome of Henoch-Schanlein purpura nephritis.Pediatr Nephrol,2007,22(10):1717-1722.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn